Share
18,370 Posts.
lightbulb Created with Sketch. 5231
clock Created with Sketch. 17/02/25
09:47
Share
Originally posted by Silverchair:
↑
I was waiting for this notice, the shorters have been pouring in tens of thousands of fake shares into the market every day with Clinuvel according to ASIC (you would think the Seller would have run out of shares long ago if they were a real holder?). Amazingly another 200 thousand fake Sell liquidity shares in just the last eight days ASIC data is available and this is on the back of Jefferies releasing their very confident share price target of $39.20 for CUV, great photos from the blockbuster Phase 3 trial, great news from the trial for children 12-17, Canada submission and Argentinian distribution agreement. So shorters throwing a lot of fake shares into the pool to control the price as they always do after good news. Cash burning Disc LOST $76.4 Million USD ($116 M AUD) last year running Phase 1 and 2s while CUV made last FY $35.6 Million PROFIT after taxes . Disc: Market cap $3.0 Billion CUV: Market cap $0.57 Billion Don't have to share profits with anyone or pay royalties or milestone payments either at Clinuvel. All IMO DYOR
Expand
Seems like a bet that half year results will disappoint. Perhaps bigger costs associated with the clinical trial than expected. Not a bet I’d be making at these prices, especially as it wouldn’t really be a concern to me personally (I’d like to see them get more aggressive with spending on growth), but gamblers will gamble.
